Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial by Oza, Amit M, Prof, Cibula, David, Prof, Benzaquen, Ana Oaknin, MD, Poole, Christopher, Prof, Mathijssen, Ron H J, Prof, Sonke, Gabe S, MD, Colombo, Nicoletta, MD, Špaček, Jiří, MD, Vuylsteke, Peter, MD, Hirte, Holger, MD, Mahner, Sven, MD, Plante, Marie, MD, Schmalfeldt, Barbara, Prof, Mackay, Helen, MD, Rowbottom, Jacqui, PhD, Lowe, Elizabeth S, MD, Dougherty, Brian, PhD, Barrett, J Carl, PhD, Friedlander, Michael, Prof

Get full text

HER2 and TOP2A as predictive markers for anthracycline-containing chemotherapy regimens as adjuvant treatment of breast cancer: a meta-analysis of individual patient data by Leo, Angelo Di, Dr, Desmedt, Christine, PhD, Bartlett, John M S, Prof, Piette, Fanny, PhD, Ejlertsen, Bent, MD, Pritchard, Kathleen I, Prof, Larsimont, Denis, MD, Poole, Christopher, Prof, Isola, Jorma, Prof, Earl, Helena, Prof, Mouridsen, Henning, MD, O'Malley, Frances P, MD, Cardoso, Fatima, MD, Tanner, Minna, MD, Munro, Alison, PhD, Twelves, Chris J, Prof, Sotiriou, Christos, MD, Shepherd, Lois, MD, Cameron, David, Prof, Piccart, Martine J, Prof, Buyse, Marc, PhD

Get full text

Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT): an open-label, phase III, randomised controlled trial by Ellis, Paul, Dr, Barrett-Lee, Peter, Prof, Johnson, Lindsay, BSc, Cameron, David, Prof, Wardley, Andrew, MD, O'Reilly, Susan, MD, Verrill, Mark, FRCP, Smith, Ian, Prof, Yarnold, John, Prof, Coleman, Robert, Prof, Earl, Helena, FRCP, Canney, Peter, MD, Twelves, Chris, Prof, Poole, Christopher, Prof, Bloomfield, David, FRCR, Hopwood, Penelope, Prof, Johnston, Stephen, FRCP, Dowsett, Mitchell, Prof, Bartlett, John MS, Prof, Ellis, Ian, Dr, Prof, Peckitt, Clare, MSc, Hall, Emma, PhD, Bliss, Judith M, Prof

Get full text

Predictive markers of anthracycline benefit: a prospectively planned analysis of the UK National Epirubicin Adjuvant Trial (NEAT/BR9601) by Bartlett, John MS, Prof, Munro, Alison F, MSc, Dunn, Janet A, PhD, McConkey, Christopher, MSc, Jordan, Sarah, MSc, Twelves, Chris J, Prof, Cameron, David A, Prof, Thomas, Jeremy, MBBS, Campbell, Fiona M, MSc, Rea, Daniel W, PhD, Provenzano, Elena, MBBS, Caldas, Carlos, Prof, Pharoah, Paul, BMBCh, Hiller, Louise, PhD, Earl, Helena, MBBS, Poole, Christopher J, Prof

Get full text

Addition of gemcitabine to paclitaxel, epirubicin, and cyclophosphamide adjuvant chemotherapy for women with early-stage breast cancer (tAnGo): final 10-year follow-up of an open-l... by Earl, Helena M, Professor, Hiller, Louise, PhD, Howard, Helen C, PhD, Dunn, Janet A, Prof, Young, Jennie, BA, Bowden, Sarah J, PhD, McDermaid, Michelle, Waterhouse, Anna K, BSc, Wilson, Gregory, FRCP, Agrawal, Rajiv, FRCR, O'Reilly, Susan, MD, Bowman, Angela, MB ChB, Ritchie, Diana M, MD, Goodman, Andrew, MB ChB, Hickish, Tamas, Prof, McAdam, Karen, FRCP, Cameron, David, Prof, Dodwell, David, Prof, Rea, Daniel W, FRCP, Caldas, Carlos, Prof, Provenzano, Elena, PhD, Abraham, Jean E, PhD, Canney, Peter, MD, Crown, John P, Prof, Kennedy, M John, Prof, Coleman, Robert, Prof, Leonard, Robert C, Prof, Carmichael, James A, MD, Wardley, Andrew M, Prof, Poole, Christopher J, Prof

Get full text